Does DIGOXIN Cause Ventricular hypertrophy? 6 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Ventricular hypertrophy have been filed in association with DIGOXIN (Digoxin). This represents 0.1% of all adverse event reports for DIGOXIN.
6
Reports of Ventricular hypertrophy with DIGOXIN
0.1%
of all DIGOXIN reports
3
Deaths
5
Hospitalizations
How Dangerous Is Ventricular hypertrophy From DIGOXIN?
Of the 6 reports, 3 (50.0%) resulted in death, 5 (83.3%) required hospitalization.
Is Ventricular hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DIGOXIN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does DIGOXIN Cause?
Toxicity to various agents (1,371)
Bradycardia (896)
Dyspnoea (762)
Nausea (762)
Vomiting (715)
Acute kidney injury (708)
Fatigue (638)
Dizziness (616)
Diarrhoea (607)
Drug ineffective (568)
What Other Drugs Cause Ventricular hypertrophy?
AMLODIPINE (46)
PREDNISONE (37)
PANTOPRAZOLE (36)
ASPIRIN (32)
VALSARTAN (29)
CLOZAPINE (28)
ACETAMINOPHEN (27)
TIOTROPIUM (24)
ALBUTEROL (21)
ONDANSETRON (21)
Which DIGOXIN Alternatives Have Lower Ventricular hypertrophy Risk?
DIGOXIN vs DIHYDRALAZINE
DIGOXIN vs DIHYDROCODEINE
DIGOXIN vs DIHYDROERGOTAMINE
DIGOXIN vs DILANTIN
DIGOXIN vs DILANTIN-125